Dibutylone
Appearance
Names | |
---|---|
Systematic IUPAC name
1-(Benzo[d][1,3]dioxol-5-yl)-2-(dimethylamino)butan-1-one | |
Other names
1-(1,3-Benzodioxol-5-yl)-2-(dimethylamino)butan-1-one; β-Keto-dimethylbenzodioxolylbutanamine; bk-DMBDB
| |
Identifiers | |
3D model (JSmol)
|
|
ChemSpider | |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C13H17NO3 | |
Molar mass | 235.283 g·mol−1 |
Pharmacology | |
Legal status |
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Dibutylone (bk-DMBDB[2]) is a stimulant drug of the amphetamine, phenethylamine, and cathinone drug classes. It is structurally related to butylone, a designer drug that has been detected in products marketed as bath salts or plant food.[3]
In 2018, dibutylone was the third most common drug of the cathinone class to be identified in Drug Enforcement Administration seizures.[4]
Legal status
[edit]In United States, dibutylone is on the list of Schedule I Controlled Substances as a positional isomer of pentylone.[5]
References
[edit]- ^ Anvisa (2023-07-24). "RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 804 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-07-25). Archived from the original on 2023-08-27. Retrieved 2023-08-27.
- ^ "Southern Association of Forensic Scientists". Archived from the original on 2013-03-25. Retrieved 2012-12-12.
- ^ Krotulski, Alex J; Mohr, Amanda L A; Papsun, Donna M; Logan, Barry K (2018). "Dibutylone (bk-DMBDB): Intoxications, Quantitative Confirmations and Metabolism in Authentic Biological Specimens". Journal of Analytical Toxicology. 42 (7): 437–445. doi:10.1093/jat/bky022. PMID 29554274.
- ^ "Emerging Threat Report: Annual 2018" (PDF). Special Testing and Research Laboratory, Drug Enforcement Administration.
- ^ "Controlled Substances" (PDF). Drug Enforcement Administration.